Similar articles for PMID: 32817140

Year	Number of Results
1999	1
2000	1
2002	2
2003	2
2004	1
2005	3
2006	5
2007	7
2008	3
2009	6
2010	8
2011	12
2012	9
2013	13
2014	14
2015	15
2016	12
2017	8
2018	6
2019	4
2020	9
2021	12
2022	15
2023	5
2024	0

1

Assessment of Bone Lesions with ¹⁸F-FDG PET Compared with ^99mTc Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.

van Es SC, Velleman T, Elias SG, Bensch F, Brouwers AH, Glaudemans AWJM, Kwee TC, Iersel MW, Maduro JH, Oosting SF, de Vries EGE, Schröder CP. van Es SC, et al. J Nucl Med. 2021 Feb;62(2):177-183. doi: 10.2967/jnumed.120.244640. Epub 2020 Aug 17. J Nucl Med. 2021. PMID: 32817140 Free article.

2

Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.

Qiu ZL, Xue YL, Song HJ, Luo QY. Qiu ZL, et al. Nucl Med Commun. 2012 Dec;33(12):1232-42. doi: 10.1097/MNM.0b013e328358d9c0. Nucl Med Commun. 2012. PMID: 23111353

3

Significance of hormone receptor status in comparison of 18F -FDG-PET/CT and 99mTc-MDP bone scintigraphy for evaluating bone metastases in patients with breast cancer: single center experience.

Teke F, Teke M, Inal A, Kaplan MA, Kucukoner M, Aksu R, Urakci Z, Tasdemir B, Isikdogan A. Teke F, et al. Asian Pac J Cancer Prev. 2015;16(1):387-91. doi: 10.7314/apjcp.2015.16.1.387. Asian Pac J Cancer Prev. 2015. PMID: 25640386 Free article.

4

Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT.

Krüger S, Buck AK, Mottaghy FM, Hasenkamp E, Pauls S, Schumann C, Wibmer T, Merk T, Hombach V, Reske SN. Krüger S, et al. Eur J Nucl Med Mol Imaging. 2009 Nov;36(11):1807-12. doi: 10.1007/s00259-009-1181-2. Epub 2009 Jun 6. Eur J Nucl Med Mol Imaging. 2009. PMID: 19504092

5

Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.

Ozülker T, Küçüköz Uzun A, Ozülker F, Ozpaçac T. Ozülker T, et al. Nucl Med Commun. 2010 Jun;31(6):597-603. doi: 10.1097/MNM.0b013e328338e909. Nucl Med Commun. 2010. PMID: 20224457

6

[18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy.

Hildebrandt MG, Gerke O, Baun C, Falch K, Hansen JA, Farahani ZA, Petersen H, Larsen LB, Duvnjak S, Buskevica I, Bektas S, Søe K, Jylling AM, Ewertz M, Alavi A, Høilund-Carlsen PF. Hildebrandt MG, et al. J Clin Oncol. 2016 Jun 1;34(16):1889-97. doi: 10.1200/JCO.2015.63.5185. Epub 2016 Mar 21. J Clin Oncol. 2016. PMID: 27001573

7

Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.

Minamimoto R, Loening A, Jamali M, Barkhodari A, Mosci C, Jackson T, Obara P, Taviani V, Gambhir SS, Vasanawala S, Iagaru A. Minamimoto R, et al. J Nucl Med. 2015 Dec;56(12):1862-8. doi: 10.2967/jnumed.115.162610. Epub 2015 Sep 24. J Nucl Med. 2015. PMID: 26405167 Free article.

8

Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer.

Al-Muqbel KM, Yaghan RJ. Al-Muqbel KM, et al. Medicine (Baltimore). 2016 May;95(21):e3753. doi: 10.1097/MD.0000000000003753. Medicine (Baltimore). 2016. PMID: 27227942 Free PMC article.

9

Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.

Jambor I, Kuisma A, Ramadan S, Huovinen R, Sandell M, Kajander S, Kemppainen J, Kauppila E, Auren J, Merisaari H, Saunavaara J, Noponen T, Minn H, Aronen HJ, Seppänen M. Jambor I, et al. Acta Oncol. 2016;55(1):59-67. doi: 10.3109/0284186X.2015.1027411. Epub 2015 Apr 2. Acta Oncol. 2016. PMID: 25833330

10

Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.

Lee JW, Lee SM, Lee HS, Kim YH, Bae WK. Lee JW, et al. Ann Nucl Med. 2012 Oct;26(8):627-33. doi: 10.1007/s12149-012-0622-3. Epub 2012 Jun 24. Ann Nucl Med. 2012. PMID: 22729551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

150 results

Results by year